Articles in IPOs

Renaissance Capital

Presbia prices IPO at $10, below the range

Presbia, which sells surgically implanted lenses to correct age related vision loss, raised $42 million by offering 4.2 million shares at $10, below the $11 to $13 range. Presbia will list on the... Read >>

Renaissance Capital

Entellus Medical prices upsized IPO at $17, the high end of the range

Entellus Medical, which sells a minimally invasive treatment to open obstructed sinus pathways, raised $78 million by offering 4.6 million shares (up from 4.4 million) at $17, the high end of the... Read >>

Renaissance Capital

Flexing its muscles: Flex Pharma prices upsized IPO above the range at $16

Flex Pharma, which is developing dietary supplements for the treatment of muscle cramps and spasms, raised $86 million by offering 5.4 million shares at $16, above the range of $12 to $14. The... Read >>

Renaissance Capital

Cancer biotech Kolltan Pharmaceuticals withdraws $86 million IPO

Kolltan Pharmaceuticals, an early stage biotech developing antibodies to treat solid tumors, withdrew its plans for an initial public offering on Wednesday. The company originally filed for an $86... Read >>

Renaissance Capital

It's electric: Spark Therapeutics increases proposed IPO deal size by 48% to $130 million

Spark Therapeutics, which is developing gene therapy treatments for orphan retinal dystrophies, raised the proposed deal size for its upcoming IPO on Wednesday. The Philadelphia, PA based company... Read >>

Renaissance Capital

Ascendis Pharma prices upsized IPO at $18, the high end of the range

Ascendis Pharma, which is developing long acting treatments for growth hormone deficiency, raised $108 million by offering 6 million shares (vs. 5 million originally planned) at $18, the high end... Read >>

Renaissance Capital

Shake Shack increased proposed range to $17 to $19

Shake Shack, a fast casual burger chain with 36 US and 27 international locations, raised the proposed deal size for its upcoming IPO on Wednesday. The New York, NY based company now plans to... Read >>

Renaissance Capital

Five high-profile internet and tech IPOs poised to launch in 2015

While Alibaba's record setting IPO will not be topped in 2015, there are several high profile tech and internet names that could be banner offerings for 2015. The most notable of our group is on... Read >>

Renaissance Capital

Zosano Pharma prices IPO at $11 midpoint, one day after boosting deal size 43%

Zosano Pharma, which is developing a transdermal formulation of an approved osteoporosis treatment, raised $50 million on Tuesday by offering 4.5 million shares (upsized from 4.3 million shares)... Read >>

Renaissance Capital

Gas pipelines go public: Columbia Pipeline Partners LP sets terms for $800 million IPO

Columbia Pipeline Partners LP, an MLP spun out of NiSource to own natural gas pipelines and storage systems, announced terms for its IPO on Monday. The Houston, TX based company plans to raise... Read >>

Displaying 1-10 of 3089
<< first < previous 1 2 3 4 5 50 100 150 200 250 300 last >>